PPL + Cholangiocytes Define a Pro‐Regenerative Subset Associated With NRG1 – ERBB3 – PI3K / AKT Signalling During Liver Fibrosis
Liver International · 2026-06 · 46 (6)
DOI: 10.1111/liv.70698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 16.05.2026. Verfasst von Meiyining Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Neuregulin-1, Liver Cirrhosis, Liver Regeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China-Guangdong Joint Fund.
Abstract (Originalsprache)
Background & Aims Chronic biliary injury drives liver fibrosis, yet mechanisms governing injury resolution and hepatocyte regeneration remain unclear. Periplakin (PPL), a cholangiocyte‐enriched cytoskeletal linker, is upregulated during biliary injury, but its functional contribution to fibrosis and repair has not been defined.
Methods
Single‐nucleus RNA‐seq (snRNA‐seq) datasets from wild‐type and DDC‐treated mouse livers were analysed to map PPL expression. Hepatic PPL‐overexpression and knockdown models were generated using adenoviral (Ad) and adeno‐associated viral (AAV) vectors, respectively. Fluorescence‐activated cell sorting (FACS)‐sorted PPL + and PPL − cholangiocytes were isolated for morphological characterisation, adoptive transfer, and hepatocyte co‐culture assays. Liver fibrosis, proliferation, extracellular matrix (ECM) remodelling, cytokines, and growth factors were assessed by histology, qRT‐PCR, Western blot, ELISA, and IHC. CellChat was used to infer intercellular signalling, and NRG1‐ERBB3‐PI3K/AKT signalling was validated in vitro.
Results
SnRNA‐seq identified PPL as a cholangiocyte‐enriched marker defining a morphologically distinct subset. PPL overexpression reduced, whereas PPL knockdown aggravated, DDC‐induced fibrosis. Adoptive transfer of PPL + cholangiocytes improved liver function, limited ductular reaction and collagen deposition, increased MMP2/MMP12/MMP13/MMP14, elevated IL‐10, EGF, and HGF, and reduced TGF‐β1 and TIMP1. PPL + cholangiocytes enhanced hepatocyte proliferation in vivo and in vitro. CellChat and co‐culture assays demonstrated that PPL + cells activate hepatocytes via an NRG1‐ERBB3‐PI3K/AKT axis.
Conclusions
PPL + cholangiocytes represent a pro‐regenerative epithelial subset that is associated with attenuated fibrosis and enhanced hepatocyte proliferation, potentially involving NRG1‐ERBB3‐PI3K/AKT signalling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
- Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, China.
- Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- South China University of Technology School of Medicine, Guangzhou, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China-Guangdong Joint Fund
Zitieren
APA
Xu, M., Huang, Y., Jiang, K., Zhang, L., Huang, W., Shen, J., Lei, J., Huang, Y., Sun, X., & Wu, Z. (2026). PPL + Cholangiocytes Define a Pro‐Regenerative Subset Associated With NRG1 – ERBB3 – PI3K / AKT Signalling During Liver Fibrosis. Liver International, 46(6). https://doi.org/10.1111/liv.70698
Vancouver
Xu M, Huang Y, Jiang K, Zhang L, Huang W, Shen J, et al. PPL + Cholangiocytes Define a Pro‐Regenerative Subset Associated With NRG1 – ERBB3 – PI3K / AKT Signalling During Liver Fibrosis. Liver International. 2026;46(6). doi:10.1111/liv.70698
BibTeX
@article{Xu2026,
author = {Xu, Meiyining and Huang, Yun and Jiang, Kefeng and Zhang, Lichao and Huang, Wanxian and Shen, Jia and Lei, Junxia and Huang, Yan and Sun, Xi and Wu, Zhongdao},
title = {PPL + Cholangiocytes Define a Pro‐Regenerative Subset Associated With NRG1 – ERBB3 – PI3K / AKT Signalling During Liver Fibrosis},
journal = {Liver International},
year = {2026},
volume = {46},
number = {6},
doi = {10.1111/liv.70698}
}
EUVIMED